A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation
Clinical trial NCT06297629 · WITHDRAWN
Trial details
- NCT number
- NCT06297629
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2024-07-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.